Skip to content

A clinical trial on SAARANAI CHOORANAM in the management of RATHTHA KOTHIPPU (SYSTEMIC HYPERTENSION)

A Prospective Open labelled non Randomized phase II clinical trial on SAARANAI CHOORANAM in the management of RATHTHA KOTHIPPU (SYSTEMIC HYPERTENSION)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/040776
Enrollment
40
Registered
2022-03-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Saaranai chooranam: 20milligram/body weight twice a day with ghee/jaggery for 45 days Control Intervention1: Nil: 0

Sponsors

Government siddha medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient presenting with the conditions such as known systemic hypertension - Stage II (>=140/ >=90 mm/hg), AHA, Hyperlipidemia, Diabetic mellitus - Type II, Choronic alcoholism, Smoking.

Exclusion criteria

Exclusion criteria: 1.Age group below 34 years and above 71 years. 2.Patients presenting with the following conditions, such as Known malignant Hypertension, Ischaemic heart disease, Chronic kidney disease, Chronic liver disease, Pregnancy, Lactating mother.

Design outcomes

Primary

MeasureTime frame
The outcome will be aimed at reducing the systemic hypertension. If during or after treatment systolic blood pressure below or equal to 130mmHg and diastolic blood pressure below or equal to 90mmHg it will be considered as successful outcome.Timepoint: 45 days

Secondary

MeasureTime frame
1.To evaluate the pharmacological activities of trial drug. 2.Study about the prevalance of Raththa kothippu (Systemic Hypertension) in relation between diet and life style. 3.To evaluate safety profile for acute and sub acute toxicity of trail drug. 4.To perform biochemical analysis. Timepoint: 45 days

Countries

India

Contacts

Public ContactProf DrAManoharan MDs PhD

Government Siddha Medical college and hospital.

sukgsmc2014@gmail.com8072685509

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026